Q: How does Urispas work?

Mechanism of Action Urispas contains the active ingredient flavoxate, which is classified as a urinary antispasmodic. It works by exerting a direct relaxing effect on the smooth muscles of the urinary tract, including the bladder. By relaxing these muscles, the medication helps to manage several symptoms associated with urinary irritation: Reducing Spasms: It counteracts involuntary muscle contractions in the bladder and urinary tract that cause pain and discomfort. Improving Control: By calming the bladder muscle, it helps decrease the sudden, intense urge to urinate (urgency) and reduces the number of times a person needs to urinate (frequency). Local Relief: In addition to its muscle-relaxing properties, the medication may provide mild local anesthetic and pain-relieving effects directly within the urinary system to further soothe irritation.

Q: What are the active ingredients in Urispas?

The active ingredient in Urispas is Flavoxate hydrochloride .

Q: What are the side effects of Urispas?

Common side effects of Urispas may include: dry mouth drowsiness dizziness and others Always consult with a healthcare professional about potential side effects.

Q: What drug class is Urispas?

Urispas belongs to the anticholinergic drug class.

Q: Is Urispas safe during pregnancy and breastfeeding?

Pregnancy There are no adequate and well-controlled studies of Urispas in pregnant women. Animal reproduction studies involving rats and rabbits at doses much higher than the standard human dose have not shown evidence of impaired fertility or harm to the fetus. However, because animal studies do not always predict how a human will respond, Urispas should be used during pregnancy only when clearly necessary. Breastfeeding It is not known whether Urispas is excreted in human breast milk. Because many drugs are passed through breast milk, caution should be exercised when Urispas is administered to someone who is breastfeeding. Discuss the potential risks to the infant with a healthcare professional before using this medication.

Q: What is the FDA approval status of Urispas?

FDA Approval Status Urispas, which contains the active ingredient flavoxate hydrochloride, is approved by the U.S. Food and Drug Administration (FDA) for the relief of symptoms caused by urinary tract irritation. It is available only with a prescription from a healthcare provider. Approved Indications The FDA has approved Urispas for the symptomatic relief of several conditions, including cystitis (bladder inflammation), prostatitis (prostate inflammation), and urethritis (inflammation of the urethra). It is used to manage the following symptoms: Painful or difficult urination Urgent need to urinate Frequent urination, including at night Pain in the lower abdominal area Urinary incontinence Boxed Warnings and REMS There are currently no FDA boxed warnings or Risk Evaluation and Mitigation Strategies (REMS) associated with Urispas. It is important to note that while Urispas treats the symptoms of urinary tract irritation, it is not used to treat the underlying infection or condition itself.

Question 1

What is Urispas?

Accepted Answer

Urispas is a prescription medication classified as a urinary antispasmodic. It works by directly relaxing the smooth muscles found in the bladder and urinary system to help manage muscle spasms.

Question 2

What is Urispas used for?

Accepted Answer

Urispas is used to treat urinary symptoms due to bladder spasm.

Question 3

How does Urispas work?

Accepted Answer

Mechanism of Action

Urispas contains the active ingredient flavoxate, which is classified as a urinary antispasmodic. It works by exerting a direct relaxing effect on the smooth muscles of the urinary tract, including the bladder.

By relaxing these muscles, the medication helps to manage several symptoms associated with urinary irritation:

Reducing Spasms: It counteracts involuntary muscle contractions in the bladder and urinary tract that cause pain and discomfort.
Improving Control: By calming the bladder muscle, it helps decrease the sudden, intense urge to urinate (urgency) and reduces the number of times a person needs to urinate (frequency).
Local Relief: In addition to its muscle-relaxing properties, the medication may provide mild local anesthetic and pain-relieving effects directly within the urinary system to further soothe irritation.

Question 4

What are the active ingredients in Urispas?

Accepted Answer

The active ingredient in Urispas is Flavoxate hydrochloride.

Question 5

What are the side effects of Urispas?

Accepted Answer

Common side effects of Urispas may include:

dry mouth
drowsiness
dizziness
and others

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Urispas?

Accepted Answer

Urispas belongs to the anticholinergic drug class.

Question 7

What is the dosage of Urispas and how do I take it?

Accepted Answer

Urispas comes as a tablet to be taken by mouth. It is usually prescribed to be taken several times a day. Follow the directions on your prescription label carefully and ask your healthcare provider to explain any part you do not understand.

Food and Administration

You may take this medication with or without food.
If the medicine causes stomach upset, taking it with food or milk may help reduce this effect.

Missed Dose

If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take extra medicine to make up for a missed dose.

Question 8

Is Urispas safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

There are no adequate and well-controlled studies of Urispas in pregnant women. Animal reproduction studies involving rats and rabbits at doses much higher than the standard human dose have not shown evidence of impaired fertility or harm to the fetus. However, because animal studies do not always predict how a human will respond, Urispas should be used during pregnancy only when clearly necessary.

Breastfeeding

It is not known whether Urispas is excreted in human breast milk. Because many drugs are passed through breast milk, caution should be exercised when Urispas is administered to someone who is breastfeeding. Discuss the potential risks to the infant with a healthcare professional before using this medication.

Question 9

What forms and strengths does Urispas come in?

Accepted Answer

Urispas is available for administration in the following form:

Oral Tablet: This medication is designed to be swallowed and is taken by mouth as directed by a healthcare provider.

Question 10

What is the FDA approval status of Urispas?

Accepted Answer

FDA Approval Status

Urispas, which contains the active ingredient flavoxate hydrochloride, is approved by the U.S. Food and Drug Administration (FDA) for the relief of symptoms caused by urinary tract irritation. It is available only with a prescription from a healthcare provider.

Approved Indications

The FDA has approved Urispas for the symptomatic relief of several conditions, including cystitis (bladder inflammation), prostatitis (prostate inflammation), and urethritis (inflammation of the urethra). It is used to manage the following symptoms:

Painful or difficult urination
Urgent need to urinate
Frequent urination, including at night
Pain in the lower abdominal area
Urinary incontinence

Boxed Warnings and REMS

There are currently no FDA boxed warnings or Risk Evaluation and Mitigation Strategies (REMS) associated with Urispas. It is important to note that while Urispas treats the symptoms of urinary tract irritation, it is not used to treat the underlying infection or condition itself.

Question 11

What should I know about Urispas and withdrawal?

Accepted Answer

Withdrawal and Dependence

Based on available medical literature, Urispas (flavoxate) is not associated with physical dependence or addiction. There is no evidence to suggest that stopping the medication causes withdrawal symptoms.

Because this drug does not cause dependence, a tapering schedule is typically not required when ending treatment. However, patients should be aware of the following:

Recurrence of symptoms: The bladder spasms, pain, or urinary frequency that the medication was treating may return once the drug is no longer in your system.
Consultation: It is recommended to speak with a healthcare professional before stopping Urispas to ensure that your symptoms are properly managed through other means if necessary.

Urispas

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

Found an Error?

Find Discounts for Urispas

Hospitals.net Disclosure